» Articles » PMID: 32641781

The Genome Insights of Streptomyces Lannensis T1317-0309 Reveals Actinomycin D Production

Overview
Date 2020 Jul 10
PMID 32641781
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The members of Streptomyces have been identified as a major source of antimicrobial agents with broad spectrum. This study is mainly focused on bioactivity-guided isolation and characterization of bioactive molecule from strain Streptomyces sp. T1317-0309 and its whole-genome sequence analysis for possible isolation of novel natural products. Strain Streptomyces sp. T1317-0309 showed 100% sequence similarity with strain Streptomyces lannensis TA4-8 consisting 10, 453,255 bp of genome with 5 scaffolds and 69.9 mol% G + C content. The genome analyses revealed a total of 17 putative biosynthetic gene clusters (BGCs) responsible for various secondary metabolites including actinomycin, bacteriocin, ectoine, melanin, terpene, siderophore, betalactone, NRPS, T2PKS, and T3PKS. The BGC and bioactivity-guided purification of ethyl acetate extract of strain T1317-0309 showed the great potency of antimicrobial activities against various gram-positive multi-drug resistant human pathogens including MRSA. The BGC-predicted bioactive secondary metabolite was identified by various NMR analyses and confirmed as actinomycin D. In addition, this study reveals the first genome study of Streptomyces lannensis as a novel source for actinomycin D.

Citing Articles

Anti-Klebsiella pneumoniae activity of secondary metabolism of Achromobacter from the intestine of Periplaneta americana.

Ma Y, Guo P, Chen X, Xu M, Liu W, Jin X BMC Microbiol. 2023; 23(1):162.

PMID: 37277707 PMC: 10240788. DOI: 10.1186/s12866-023-02909-7.

References
1.
Prestinaci F, Pezzotti P, Pantosti A . Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015; 109(7):309-18. PMC: 4768623. DOI: 10.1179/2047773215Y.0000000030. View

2.
Dahal R, Chaudhary D . Microbial Infections and Antimicrobial Resistance in Nepal: Current Trends and Recommendations. Open Microbiol J. 2018; 12:230-242. PMC: 6110072. DOI: 10.2174/1874285801812010230. View

3.
Terra L, Dyson P, Hitchings M, Thomas L, Abdelhameed A, Banat I . A Novel Alkaliphilic Inhibits ESKAPE Pathogens. Front Microbiol. 2018; 9:2458. PMC: 6232825. DOI: 10.3389/fmicb.2018.02458. View

4.
Dahal R, Shim D, Kim J . Development of actinobacterial resources for functional cosmetics. J Cosmet Dermatol. 2017; 16(2):243-252. DOI: 10.1111/jocd.12304. View

5.
Schneider O, Simic N, Aachmann F, Ruckert C, Kristiansen K, Kalinowski J . Genome Mining of sp. YIM 130001 Isolated From Lichen Affords New Thiopeptide Antibiotic. Front Microbiol. 2019; 9:3139. PMC: 6306032. DOI: 10.3389/fmicb.2018.03139. View